Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 40 Medical Device Angel Investors in United Kingdom

Last updated: Apr 2024 A list of 40 angel investors that invest in Medical device startups based in United kingdom. We rank investors based on the number of investments they made in Medical device companies from United kingdom. We update this investor list every month.

Top 40 Medical Device Angel Investors in United Kingdom

Investor	Medical Device United Kingdom investments
Paul Heydon	3
Ariel Poler	2
Tim Dempsey	2
Mark Bamforth	2
Adam Niewinski	1
Evan Cheng	1
Leonid Shapiro	1
Martin Varsavsky	1
Charlie Songhurst	1
Nicolas Berggruen	1
Erinç Özada	1
Vince Proffitt	1
Jim Breyer	1
Ali Karabey	1
Flaviu Simihaian	1
Michael Bristow	1
Shishir Mehrotra	1
Inaki Berenguer	1
John Lloyd	1
Ilkay Gundogan	1
Barnaby Cardwell	1
Elan Katz	1
Yusuf Hamied	1
Agah Uğur	1
Robert Marshall	1
Maurice Ferre, M.D.	1
George Robinson	1
Jon Claydon	1
Jonathan Milner	1
E. U.	1
Manny Kadre	1
John Spearman	1
Carlos Gallardo	1
Paul Thandi	1
Imran Hakim	1
Patrick Hurst	1
Bob Davis	1
Arjun Desai	1
Guillaume Glaunès	1
Fred Moll, M.D	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

30 years as a founder, operator, investor, and advisor. Previously Paul was a Co-Founder and General Partner at LVP. Paul has invested in Supercell (majority acquired by Tencent), Unity (NYSE:U), Matchmade, Radiant Entertainment (acquired by Riot Games), Boomlagoon (acquired by Wargaming), Peak (acquired by Hachette Livre), AppOnboard, FRVR,Starform, Gameclub, Coherence, Lucid Sight, Doppio Games, Capture, Flick, EvenPrime, Tellie & Litho and others. Previously, he was an investment banker at Avista Partners, Commerzbank Securities & ING Barings. He has both a HBA & MBA from the Richard Ivey School of Business at University of Western Ontario in Canada.

Investment focus

Software, Gaming, Mobile Apps
Seed, Series A, Pre-Seed
United States, United Kingdom, Finland

Portfolio highlights

Tellie — Create a free website/link-in-bio to market your art, release new music, increase your followers, sell merchandise, and share your portfolio/resume/EPK. Token Gate all.
Coherence — Unlock your multiplayer possibilities
Glean AI — Glean AI is the only Accounts Payable solution that combines smart automation with spend intelligence and powers Finance teams to drive material savings.

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

Investment focus

Software, Social Media, Internet
Seed, Series A, Angel
United States, Mexico, United Kingdom

Portfolio highlights

Reloadly — Reloadly makes it easy for developers to connect with Mobile operator services. We are disrupting a Trillion dollar industry! Mobile Operators are stuck in old school business models, where most of the world is moving to open source platforms for developers to build amazing products. Reloadly is bridging the gap between mobile operators anddevelopers, and at the same time creating new sales channels for the 816 mobile operators around the world.
Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
humm — humm harnesses cutting-edge neuroscience into products that allow people to learn faster and perform better.humm is working to bring the incredible results of neuroscience research out of the lab and into non-invasive wearables that improve the quality of life for everyday people. Our first product is a clinically validated patch that you wearfor 15 minutes to get up to 90 minutes of improved working memory, by gently stimulating the signals in the part of the brain that controls your executive thinking. humm improves your ability to learn and be at your best, allowing people to reconnect with the joy of learning and challenge themselves to continue growing at any stage of life, whether it's for work or personal enjoyment!

Tim Dempsey is a Managing Partner at Epiphany Capital. He graduated from the University of Manchester.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
United Kingdom

Portfolio highlights

Lunio — Drive performance marketing efficiency by cutting out invalid traffic across all paid marketing channels. Reach more users with the same ad spend.
Mitra bio — We are transforming skin-care by approaching ageing as a disease to be fought. We are developing a genetic and epigenetic discovery platform to help skincare companies find and develop new compounds that actually fight the root cause of skin ageing.
PPC Protect — Drive performance marketing efficiency by cutting out invalid traffic across all paid marketing channels. Reach more users with the same ad spend.

Mark Bamforth is the Operating Partner at Ampersand Capital Partners.

Investment focus

Medical, Health Care, Biotechnology
Series A, Funding Round, Seed
United Kingdom, United States

Portfolio highlights

Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
PneumoWave — Empowering Intervention and Prevention for Opioid-Induced Respiratory Depression
Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.

Co-Founder and General Partner in OTB Ventures Graduated from the Warsaw School of Economics and is also Alumni of Stanford University - Graduate School of Business. Founder and CEO of Expander (Poland) as well as Co-Founder of Platinum Bank (Ukraine). Adam Niewiński started his professional career in 1997 at The Boston Consulting Group where heworked as a consultant specialized in financial services sector. As of 2000 he was building a team, acquired financing and subsequently established Expander, which became probably the first polish FinTech. Since 2002 up till 2017 had been associated with the UniCredit Group where he started working in the Central Brokerage House of Bank Pekao S.A. as Deputy CEO responsible for all business activities (investment banking and wealth management). Next, he became CEO of Xelion Investment House – a failed corporate start up that he successfully relaunched to become a leading platform for Personal Financial Advisers with $1b of AuA. In 2015 he was appointed Deputy CEO of Bank PEKAO SA responsible for Private Banking Division as well as Small and Mid Corpo acquisition and financing. He was also the Chairman of the Supervisory Board of Xelion Investment House, Chairman of the Supervisory Board of Private Equity Managers, Deputy Chairman of the Supervisory Board of Central Brokerage House of Bank Pekao S.A., Member of the Supervisory Board of Pekao Investment Banking, and Member of the Management Board of the Society for the Encouragement of Fine Arts by the Zachęta Gallery – National Gallery of Art.

Investment focus

FinTech, Financial Services, Artificial Intelligence
Series A, Seed, Funding Round
Poland, Singapore, United States

Portfolio highlights

ITaxi — ITaxi is a free mobile application, allowing its users to order cabs through its application. Its users do not have to know Polish to use the application as they can decide by type and model of the car, rate per kilometer, and time.ITaxi cooperates with local taxi federations and it has fleet of 10, 000 vehicles in over 100 cities all over thecountry, including Warsaw, Cracow, Lodz, Wroclaw, Gdansk, and Poznan. Launched in 2012 the application is based in Poland.
Credolab — An alternative credit scoring solution based on alternative data (smartphone and web metadata)
Audioteka — Audioteka is a mobile and multi-language audiobook application for smartphones/tablets with a dedicated audiobook car platform. They offer audiobooks in 9 languages in 23 countries.They strive to bring stories back into the lives of busy people through the creative use of technologies. They want everyone to try an audiobook at least once.They're confident you'll enjoy this new medium. People really can be smarter and better entertained thanks to their stories.They edit and produce audiobooks, collaborate with actors, inspire new and innovative productions and in doing so they offer unique content that can’t be found in any other audiobook store. Audioteka strives to give its customers the highest quality content via ready-to-use mobile solutions. They understand their mobile users and continue to learn from them every day. That is why they've created the world's most seamless platform for enjoying valuable spoken word content while on the go!

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Funding Round, Pre-Seed
United States, United Kingdom, Australia

Portfolio highlights

PARSIQ — Explore the future of blockchain with PARSIQ - Your gateway to advanced blockchain monitoring, smart triggers, and real-time intelligence. Empower your crypto journey with cutting-edge technology and unparalleled insights. Join us in revolutionizing the way you interact with the blockchain ecosystem
Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.
Kernal Biologics — Kernal biologics is an onco-selective mRNA therapeutics company located in Cambridge, MA

Leonid Shapiro is a managing partner at Candesic. He is also a partner at Brookstreet Equity Partners. Prior to joining Brookstreet, Leonid served as an engagement manager at McKinsey & Company.

Investment focus

Health Care, Medical Device, Nanotechnology
Seed
United Kingdom

Portfolio highlights

FluoretiQ — FluoretiQ is a medical device company designing simple and effective bacterial detection systems for rapid diagnosis of infection. They developing a new solution that combines proprietary nanomaterials and optical sensing technologies to enable the identification of harmful bacteria in minutes. The company nanotechnology utilizes receptor-mediatedsensing and Quantum-enhanced optics for the rapid identification of bacterial infection.FluoretiQ developed NANOPLEXa rapid diagnostic platform that identifies and enumerates bacterial pathogens in less than 15 minutes. The NANOPLEXa ensures that patients receive the most effective antibiotic treatment from the start. Their products easy-to-use, providing clinicians with the data to support accurate-same-day diagnosis and more appropriate antibiotic selection.FlouretiQ was founded in 2017 and is headquartered in Bristol, United Kingdom.

Martin Varsavsky is the Founder and Chairman of Gameto. He previously worked at Fon as a Chairman. Martin Varsavsky attended Columbia Business School.

Investment focus

Social Media, Health Care, Mobile
Seed, Series A, Angel
United States, United Kingdom, Spain

Portfolio highlights

Outdid — Verify identities with no storage, processing, or access of private personal information
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.

Charles Songhurst is a founding partner of Katana Capital, a long-short equity hedge fund. He also runs the Songhurst Group, which holds assets in a variety of private companies.Charles ran corporate strategy for Microsoft and focused on partnering and M&A. He was involved in the Yahoo acquisition and commercial deal, and the Skypeacquisition. Before running corporate strategy, Charles was focused on the emergence of Google and the growth of the search industry.Prior, Charles was an analyst at McKinsey & Company in London. Charles received a bachelor’s degree from Oxford University in politics, philosophy, and economics.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Germany

Portfolio highlights

Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
StackOne — Accelerate your SaaS growth with our unified API solution for HRIS, ATS, and CRM. Say "yes" to customers, build advanced integrations quickly, and experienced the best data privacy controls in the market.
Utila — Utila is an enterprise-scale self-custody platform that manages your organization's crypto strategy with safe, chain-agnostic wallet infrastructure.

Nicolas Berggruen is the Founder and Chairman of the Berggruen Institute. He attended New York University.

Investment focus

Software, Machine Learning, Artificial Intelligence
Seed, Series A, Series B
United States, United Kingdom, Brazil

Portfolio highlights

Helm.ai — Helm.ai is a scalable artificial intelligence for autonomous vehicle.
Story Protocol — Story Protocol is building open IP infrastructure to grow the creativity of the internet era.
iLoF — iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development

Erinç Özada is an angel investor.

Investment focus

Apps, Baby, Gaming
Seed
Turkey, United Kingdom

Portfolio highlights

WeWALK — WeWALK, making the white cane innovative and smart, allows visually impaired people to walk more independently and safely and thanks to its three revolutionary features, it promotes their participation in social life on an equal foot with everyone.Obstacle detection: : WeWALK detects obstacles at head and chest level with its onboard ultrasonicsensor and warns its users with vibration patterns.Pairs with smart phones: : When connected with the WeWALK application via Bluetooth, GPS navigation is easy with WeWALK without the need to take out the phone.It gets better with new integrations: Every integration made possible with software updates brings new features to WeWALK. With its smart city solutions, WeWALK enables visually impaired people to access beneficial information around them such as nearby cafes and shops, while also providing them the info for closest public transport stops and arrival times. WeWALK has been developed so that it can gain new features such as nde hailing in the future with its ability to be integrated with new applications. WeWALK integrations developed so far include "Google Maps" and Alexa virtual assistant service.
Fomo Games — We are a fast growing mobile game developer based in Istanbul. Our team comprises experienced gaming designers, marketing, data and technology experts as well as successful business builders.
Revel Games — Revel Games engages in the creation of mobile gaming apps.

Vince Proffitt is the Founder and President of Spartan Medical. He attended United States Air Force Academy.

Investment focus

Medical Device
Seed
United Kingdom

Portfolio highlights

Sure — The Sure Retractor System offers physicians a radiolucent, single-use, sterile retractor which reduces X-ray exposure for the patient and surgical team, thereby offering a safer working environment for all staff while also reducing OR time.

Jim Breyer - Co-Founder @ Accel-KKR

Investment focus

Health Care, Information Technology, Artificial Intelligence
Series B, Series A, Series C
United States, United Kingdom, Singapore

Portfolio highlights

Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.

Ali Karabey is a managing director at 212, a venture capital fund that focuses on investments in internet, communication and technology companies.Karabey also currently serves on the boards of several e-commerce companies, including Butigo.com, an online fashion retail start-up focusing on fast fashion; Balerin.com, a front-runner in theonline personal care vertical; and Hazinem.com, an online jewelry store.After graduating from the University of Michigan with a degree in finance, Ali resumed his career in Arthur Andersen’s New York office in the Corporate Finance department, executing mid-market transactions in the technology, media and telecommunications industries.In 2002, he joined Morgan Stanley Capital International and managed North American and European finance teams consecutively. He was also involved in the valuation, due diligence, and post-acquisition integration of acquisition targets.After Morgan Stanley, Karabey transferred to Deutsche Bank and focused on the bank’s principal investments.Prior to 212, Karabey moved back to Istanbul in 2008, where he provided consultancy services to clients in the government and private sector on PPP, project finance, and private equity advisory projects. Karabey is a member of Galata Business Angels, Istanbul’s premier angel investor organization, and also serves on the Endeavor Advisory Board.

Investment focus

Software, iOS, Marketing
Seed, Series A, Pre-Seed
United States, United Kingdom, Turkey

Portfolio highlights

WeWALK — WeWALK, making the white cane innovative and smart, allows visually impaired people to walk more independently and safely and thanks to its three revolutionary features, it promotes their participation in social life on an equal foot with everyone.Obstacle detection: : WeWALK detects obstacles at head and chest level with its onboard ultrasonicsensor and warns its users with vibration patterns.Pairs with smart phones: : When connected with the WeWALK application via Bluetooth, GPS navigation is easy with WeWALK without the need to take out the phone.It gets better with new integrations: Every integration made possible with software updates brings new features to WeWALK. With its smart city solutions, WeWALK enables visually impaired people to access beneficial information around them such as nearby cafes and shops, while also providing them the info for closest public transport stops and arrival times. WeWALK has been developed so that it can gain new features such as nde hailing in the future with its ability to be integrated with new applications. WeWALK integrations developed so far include "Google Maps" and Alexa virtual assistant service.
Teleporter — Teleporter is the World of Gamers in VR that brings us together in one digital place for all the ways gamers get together. Focused on gamers, inspired by the world’s best MMORPGs, and amplified by video-gaming enthusiasts, we dream of building a universe for gamers using technology, artistry, and magic.Our players in Teleporter can play manybuilt-in games, watch game streams, find like-minded others, and hang out together in fantastic 3D environments. Teleporter: WoG universe feels like and works like a game, but it also allows players to do many different things they usually love to do with other gamers. Our dream is to shape the future of gamers getting together digitally.
TeamSQL, Inc. — TeamSQL is a Multi-Platform SQL client built for collaboration, usability and performance. It supports popular database engines used by the majority and runs on macOS, Windows and Linux.

Flaviu Simihaian is the co-founder and CEO of Troy Medicare, the first pharmacy-powered, AI-driven Medicare Advantage plan. Flaviu also co-founded and is the chairman of Amplicare (previously iMedicare), a web-based SaaS platform that 7,000 pharmacies use to manage and grow their business.

Investment focus

Health Care, FinTech, Rehabilitation
Seed
United States, United Kingdom

Portfolio highlights

Avanlee Care — Bring your family closer with the all-in-one elderly care app.
MIRA Rehab — MIRA Rehab is a company with the mission to motivate people to get better in a faster, easy and fun way.For that purpose, MIRA Rehab is developing MIRA, which is a product designed to make physical therapy fun and convenient for patients recovering from surgery or injury. The system transforms existing physical therapy exercises into video-games,and uses an external sensor to track and assess patient compliance. The sensor currently used is Microsoft Kinect, which can track the user movements from a distance, with no physical interaction required, whilst determining if the movements are being performed correctly and if the patients’ performance improves over time. The games are motivating and created for different pathologies in order to respond and adapt to patients’ needs.
Queen City Fintech — QC Fintech supports the journey of Fintech startup Founders at all stages of their entrepreneurial journey.

Michael Bristow is the CEO & Co-Founder of CP Capital. He previously worked at Peer-to-Peer Finance Association as a Board Member. Michael Bristow attended London Business School.

Investment focus

Real Estate, SaaS, Software
Seed, Equity Crowdfunding, Pre-Seed
United Kingdom, Belgium, Ireland

Portfolio highlights

RENTUU — Rentuu has been featured for the last 3 years in a row in the UK's Top 100 UK Start-Ups List, and operates a global, fast-growing, cloud-based technology platform and franchise network for the multi-billion pound sterling equipment hire industry. We’re a venture capital backed technology start-up backed by Sir Stelios Haji-Ioannou (founder ofeasyJet) and other institutional investors with the exclusive rights to the easyHire brand in a number of countries, including the UK, EU, Switzerland, South Africa, and Dubai to facilitate equipment rental for construction and party equipment.
Howsy — Howsy is a real estate management platform that provides repairs management and renewal services for landlords and tenants. Howsy. A new concept designed to shake up the way of renting works for good. Its on a mission to create a simple, intuitive and fairly priced experience that’s powered by new ideas and brilliant technology.
CrowdProperty — CrowdProperty is a specialist property project lending platform used to facilitate short-term loans. It is a profitable fintech lending innovator that matches demand that property professionals undertaking property projects and supply that is retail investors of capital for value-creating property projects that enable clients to get a better dealfor the borrowers, lenders, the under-supplied housing environment, and increased spend in the economy.The company was founded in 2013 and is headquartered in Edgbaston, Birmingham.

Mr. Shishir Mehrotra is a Co-Founder/CEO of Coda since June 2014 and served as Strategic Advisor to the Chief Executive Officer from December 2015 to May 2017. Mr. Mehrotra is the CEO and Co-Founder of Coda, Inc. He served as Vice President of Product and Engineering, Youtube/Video at Google Inc. Mr. Mehrotra served as a Director ofProduct Management for Google TV Ads and YouTube Ads at Google Inc. He served as Director of Program Management at Microsoft. He served as the Chief Executive Officer of Centrata, Inc. Prior to working with Centrata, he was part of the team that brought the Microsoft Office email client to the market. He was Director of Program Management at Microsoft. He held positions at the W3C, Taurus Telysys and the MIT Artificial Intelligence Laboratory. He is accurately regarded as one of the most knowledgeable people in digital content and technology. He has been a Director of Victorious, Inc. since July 23, 2015. He served as a Director of INVIDI Technologies Corporation. Mr. Mehrotra holds a Bachelor of Science in Computer Science and a Bachelor of Science in Mathematics from the Massachusetts Institute of Technology.

Investment focus

Software, Information Technology, Apps
Seed, Series A, Series B
United States, United Kingdom, India

Portfolio highlights

Config — Config combines engineering, operations, and manufacturing to simplify the large-scale shipment of high-quality hardware.
Arta Finance — Arta Finance is a network of innovators, researchers, finance specialists, and business executives who help people get the most of their finances. Arta offers access to financial opportunities that help people to plan and enjoy their financial future but with less complexity and lower fees. It was founded by Caesar Sengupta.
Luminai — DigitalBrain helps you get through your support tickets twice as fast.

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

Investment focus

E-Commerce, Software, FinTech
Seed, Angel, Pre-Seed
Spain, United States, United Kingdom

Portfolio highlights

Bankflip — Permissioned data technology to collect and process your customers' income, tax, employment & other relevant data & documents in real-time
Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
Mable (Neurolytic Healthcare) — Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.The company delivers digitally and genomically-drivenmedical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.

John Lloyd

Investment focus

Health Care, Education, Wellness
Seed, Funding Round, Equity Crowdfunding
United Kingdom

Portfolio highlights

Thrive — Thrive Mental Wellbeing - Mental Health Services
Easy Peasy — Get EasyPeasy parenting tips and activities, personalised for you and your 0-5 year old, from our playful community of parents and experts.
Elemental Software — Elemental is a digital platform that connects patients health and social care professionals and community health & wellness providers.Health Professionals are able to generate digital social prescriptions for citizens with chronic health risks such as depression, social isolation, type 2 diabetes and obesity, connecting them with qualityassured providers who deliver community based interventions across the domains of exercise, diet/nutrition, social support and mental health.The software is designed as a multi-tenanted cloud service and so can be implemented rapidly. It is highly parameterised and can be customised to suit an individual organisation's functional requirements without compromising its technological core.

Ilkay Gundogan

Investment focus

Health Care, Apps, Printing
Seed, Pre-Seed, Funding Round
United Kingdom, Turkey

Portfolio highlights

WeWALK — WeWALK, making the white cane innovative and smart, allows visually impaired people to walk more independently and safely and thanks to its three revolutionary features, it promotes their participation in social life on an equal foot with everyone.Obstacle detection: : WeWALK detects obstacles at head and chest level with its onboard ultrasonicsensor and warns its users with vibration patterns.Pairs with smart phones: : When connected with the WeWALK application via Bluetooth, GPS navigation is easy with WeWALK without the need to take out the phone.It gets better with new integrations: Every integration made possible with software updates brings new features to WeWALK. With its smart city solutions, WeWALK enables visually impaired people to access beneficial information around them such as nearby cafes and shops, while also providing them the info for closest public transport stops and arrival times. WeWALK has been developed so that it can gain new features such as nde hailing in the future with its ability to be integrated with new applications. WeWALK integrations developed so far include "Google Maps" and Alexa virtual assistant service.
Terra — API that enables you to integrate with wearables, such as Garmin, Fitbit, Apple, Google, Polar, Eight Sleep, Oura and Others through a single source.
Mythos Cards — Mythos Cards is the leading collectible card company of Turkey. The company holds licenses to top Turkish Super league clubs and entertainments properties. Innovation lays at the centre of Mythos Cards.

Barnaby Cardwell

Investment focus

Elderly, FinTech, Finance
Seed
United Kingdom

Portfolio highlights

Digital Home Visits Group — DHV is a tech-enabled home care provider, regulated by the CQC. Our mission is to raise the gold standard of care. We are developing an integrated care and technology service, to enable vulnerable adults to remain living independently, in the comfort of their own home, for longer. By combining home monitoring and predictive analytics, we are ableto detect health decline and prevent major health events (such as falls, UTIs and respiratory diseases), which would otherwise result in admission to hospital and loss of independence. The result? A 24/7 service, with better health outcomes, at a lower cost than live-in or residential care.
Burrow — We are pleased to announce that Burrow is now finova and has acquired BEP Systems. Read the full press release for more information or continue to the website https://www.finova.tech/ to see our full range of cloud-based software.

Elan Katz, CEO at Quick RX.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.

Investment focus

Medical, Medical Device
Seed
United Kingdom

Portfolio highlights

1inhaler — 1inhaler operates as a developer of drug delivery device.

Agah Uğur

Investment focus

Software, Apps, CRM
Seed, Funding Round, Pre-Seed
Turkey, United Kingdom

Portfolio highlights

Missafir — Missafir is a PropTech start-up in Istanbul. We are the first short/mid term home rental management company in Turkey!We deliver for our customers through a combination of thoughtful interior design and attentive hotel-style services that deliver superior earnings from short/mid term rental management through our strength in data-drivendynamic pricing solutions.
Mukellef | a Workhy Company — More than 20,000 entrepreneurs chose us for company formation, financial process management, tax return preparation, and bookkeeping services.
Robomotion — What is Robotic Process Automation - RPA? Robomotion offers you the opportunity to automate your repetitive tasks such as Browser Automation, Content Marketing, SAP or Excel!

Robert Marshall is Executive Chairman of Martlet Capital.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.

Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in 2014.In June 2007, Dr. Ferré received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, he foundedVisualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until 2002 when the company was acquired by GE Healthcare, the healthcare division of the General Electric Company. Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare, until 2004.Dr. Ferré holds an M.D. and a Master’s degree in Public Health from Boston University.

Investment focus

Medical Device, Medical, Health Care
Series A, Seed, Angel
United States, United Kingdom

Portfolio highlights

Heru — Discover the future of vision care and virtual eye exams with Heru. Click to learn about our AR eye machines and virtual visual field exams.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
DermaSensor — We've built a handheld, objective device to assist primary care providers in evaluating skin lesions for the risk of cancer in seconds. Early detection saves lives.

George Robinson is the Founder of Oxford Investment Consultants LLP. He attended the University of Oxford.

Investment focus

Software, Health Care, Mobile Apps
Angel, Series A
United Kingdom

Portfolio highlights

Navenio — Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons orwi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice.The company was founded in 2015 and is headquartered in Oxford, England.
Newrotex Ltd — Newrotex is a silk biomedical company focused on developing silk nerve stents to repair peripheral nerve damage

Jon Claydon

Investment focus

Software, SaaS, App Marketing
Seed, Angel, Pre-Seed
United Kingdom, Canada

Portfolio highlights

Zumo — Digital assets platform engineered with a focus on compliance and sustainability. Get in touch to learn more.
Be Nosy — Nosy is wearable tech with data play that helps you breathe purified air anywhere at any time. Our state of the art patented technology developed by former Dyson engineers is more effective at protecting you from pollution, viruses and allergens than any other solution in the market. While our particles and breathing sensor technology will help youknow exactly what is going into your body.
Togather — Create your event on Togather, the UK's most trusted events booking platform, choose from our roster of over 1,500 of the best and most passionate creators...

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Canada

Portfolio highlights

Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
Pencil Biosciences — Next Generation Genome Editing Tool
Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.

E. U.

Investment focus

Health Care, Apps, Social Impact
Seed, Funding Round
France, United Kingdom

Portfolio highlights

R-PUR — Premium antipollution mask since 2015
WeWALK — WeWALK, making the white cane innovative and smart, allows visually impaired people to walk more independently and safely and thanks to its three revolutionary features, it promotes their participation in social life on an equal foot with everyone.Obstacle detection: : WeWALK detects obstacles at head and chest level with its onboard ultrasonicsensor and warns its users with vibration patterns.Pairs with smart phones: : When connected with the WeWALK application via Bluetooth, GPS navigation is easy with WeWALK without the need to take out the phone.It gets better with new integrations: Every integration made possible with software updates brings new features to WeWALK. With its smart city solutions, WeWALK enables visually impaired people to access beneficial information around them such as nearby cafes and shops, while also providing them the info for closest public transport stops and arrival times. WeWALK has been developed so that it can gain new features such as nde hailing in the future with its ability to be integrated with new applications. WeWALK integrations developed so far include "Google Maps" and Alexa virtual assistant service.

Manny Kadre

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

John Spearman - Founder & Former Chief Executive @ Classic FM

Investment focus

TV, FinTech, Finance
Series A, Seed, Pre-Seed
United Kingdom

Portfolio highlights

Neyber — Join Neyber today to help improve financial wellbeing and happiness in the workplace. Financial education, affordable loans, and savings and investments paid from your salary.
Techspert — Connect to the world's leading experts and access high-quality precise knowledge fast. Easy scheduling. Dedicated project managers.
Ampersand Health — We are a social purpose company founded by doctors and patients to improve the health and happiness of people with long term inflammatory conditions.

Carlos Gallardo

Investment focus

Health Care, Medical Device, Medical
Seed, Series A
Spain, United Kingdom

Portfolio highlights

Amelia Virtual Care — Amelia, formerly Psious VR, is a Virtual Reality software for use by mental health professionals in their therapy sessions with over 100 available virtual environments.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Paul is the Founder and Chief Executive Officer of the NEC Group, the UK’s leading live events business, which owns; the NEC, ICC, Vox, Resorts World Arena, Utilita Arena Birmingham, The Ticket Factory and Amadeus.He was appointed Group CEO in 2006, bringing over 20 years’ experience in the media industry.Paul has since transformed the Groupinto a customer-centric and data-led organisation, whilst increasing its portfolio of businesses and venues, and leading the company through changes of ownership in 2015 and 2018.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

EDX Medical Group — EDX Medical Group provides innovative digital diagnostic products and services for cancer, cardiovascular disease, neurology, and infectious disease testing.

Imran Hakim, Optometrist, Inventor, and Serial Entrepreneur.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Patrick Hurst

Investment focus

3D Printing, Health Care, 3D Technology
Seed
United Kingdom

Portfolio highlights

Axial3D — Leading the way with the latest 3D imaging, models, and devices

Bob Davis is a General Partner at Highland Capital Partners and an Executive Chairman at Highland Transcend Partners. He was a CEO at Lycos. Bob attended Northeastern University and Babson College.

Investment focus

Internet, Advertising, Social Network
Series A, Series B, Series C
United States, United Kingdom

Portfolio highlights

LovePop — Buy online, personalize, schedule and send 3D pop-up cards with free shipping. Lovepop has greeting cards & paper art for every occasion. A Lovepop is a beautiful keepsake that unfolds like a miniature surprise.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Vecna Robotics — Vecna Robotics is the leading autonomous mobile robot (AMR) company that provides logistics automation and workflow optimization solutions.

Dr. Desai brings a variety of medical industry, health policy, and clinical academic experiences to Avinger. Initially joining Avinger as a consultant in 2009, Dr. Desai helped to direct and publish the pivotal CONNECT study, which successfully established FDA clearance for Avinger’s Wildcat and Kittycat CTO crossing catheters. After joiningAvinger full time in 2012, Dr. Desai has expanded his focus to oversee health economics, reimbursement, clinical evidence generation, and scientific theory. In that time, Avinger has successfully published more than twenty manuscripts, clinical conference presentations, and case series. Most recently, Dr. Desai and his team successfully conducted and published the first ever peer reviewed Lumivascular manuscripts hallmarking a large European case series and the landmark CONNECT II clinical trial for the Ocelot catheter. Prior to Avinger, Dr. Desai served as a consultant and advisor for Incline Therapeutics, developing the IONSYS transdermal fentanyl delivery system. Additionally, Dr. Desai has consulted with pharmaceutical development targeting cancer therapeutics and healthcare IT development for capture of real time quality- metric assessment and implementation.Prior to management consulting, Dr. Desai served as a fellow in the US House Policy Committee, advising members of Congress on healthcare legislation. Additionally, Dr. Desai represented the US State Department and Rotary International as an Ambassador of Goodwill to Singapore where he led vaccine prophylaxis campaigns and lectured in the department of health economics at the National University of Singapore.Dr. Desai maintains his clinical practice as adjunct faculty at Stanford University in the department of Anesthesia where he completed his advanced anesthesia residency training. Dr. Desai holds an M.D. from the University of Miami Miller School of Medicine and a B.A. in Economics from the University of Oklahoma.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Angel Investor

Investment focus

Software, E-Commerce, Apps
Seed, Funding Round, Pre-Seed
United Kingdom, United States, Kenya

Portfolio highlights

Voyage SMS — The flexible and delightful SMS marketing and message commerce platform. 30X ROAS, 30%+ CTR, and 2-5X relative list growth. Get a demo today.
Homebase — Founded in 2019 in Singapore, Homebase is one of Southeast Asia’s leading Proptech companies. Homebase provides revolutionary products made accessible that empower homeowners to buy, sell, and own homes in ways that work best for themselves. Our vision is to actualize each and every individual's dream of homeownership in Southeast Asia.Homebase is backed by leading investors and partners around the world. Our investors and partners include, but are not limited to, large global financial institutions (Shinhan Bank, Emles, ACE and Company), leading venture capital and private equity funds (Y Combinator, Goodwater Capital, VinaCapital, Partech, etc), and successful entrepreneurs and angel investors (founders and executives of disruptive companies like Divvy Homes, PropertyGuru, Zerodown, and Opendoor). Our management team comes from elite multi-national companies and institutions (McKinsey & Company, Goldman Sachs, Grab, Linkedin, University of Pennsylvania, Harvard, Caltech), and consists of diverse professionals across financial advisory, real estate, management consulting, capital markets, and technology. Homebase’s advisory board consists of founders and executives in some of the most successful and high-growth technology and proptech companies in Southeast Asia, including Alibaba, Lazada, 99.co, PropertyGuru, and Zalora.Homebase's head office is located in Ho Chi Minh City. We operate across most major cities in Vietnam in addition to smaller provincial areas in Vietnam.To learn more about Homebase, please visit our website at: https://homebase.com.vn
Rain AI — We build artificial intelligence processors, inspired by the brain. Our mission is to enable brain-scale intelligence.

Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical,Inc. (Nasdaq: ISRG).Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.

Investment focus

Medical Device, Health Care, Medical
Series A, Seed, Series B
United States, France, United Kingdom

Portfolio highlights

Neuro42 — Neuro42 is developing and commercializing advanced MRI technology for diagnosis and image-guided interventions.
Promaxo — Learn how Promaxo is revolutionizing the quality of care by bringing MRI to an office setting and enabling live MR image guidance for a wide variety of medical procedures.
Mendaera — Mendaera enables all healthcare providers to perform precise and consistent point-of-care interventions. Their platform combines real-time imaging, robotics, and artificial intelligence to aid physicians in image acquisition and interpretation.

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate